title: Inhibition of TLR-4/MD-2 signaling by RP105/MD-1.
abstract: Activation of Toll-like receptor (TLR) signaling by microbial and host molecular signatures is critical to the induction of immune responses. Such signaling is, perforce, kept under tight control. We recently discovered a novel endogenous inhibitor of TLR-4 - RP105. Initially identified as a B-cell-specific molecule with a role in B-cell proliferation in response to RP105 mAb and LPS, RP105 is a TLR-4 homologue. Further, like TLR-4 whose surface expression and signaling depends upon co-expression of the secreted protein MD-2, surface expression of RP105 is dependent upon co-expression of the MD2 homologue, MD-1. Unlike the TLRs, however, RP105 lacks a signaling domain, having the apparent structure of a TLR inhibitor. Further, RP105 is not B-cell-specific; its expression directly mirrors that of TLR-4 on dendritic cells and macrophages. These considerations suggested a role for RP105 as a physiological inhibitor of TLR-4 signaling. Indeed, we have recently found that: (i) RP105 is a specific inhibitor of TLR-4 signaling in HEK293 cells; (ii) RP105/MD-1 interacts directly with TLR-4/MD-2, inhibiting the ability of this signaling complex to bind LPS; (iii) RP105 regulates TLR-4 signaling in dendritic cells and macrophages; and (iv) RP105 regulates in vivo responses to LPS.
authors.affiliation: Division of Molecular Immunology, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
authors.forename: Senad
authors.initials: S
authors.lastname: Divanovic
authors.forename: Aurelien
authors.initials: A
authors.lastname: Trompette
authors.forename: Sowsan F
authors.initials: SF
authors.lastname: Atabani
authors.forename: Rajat
authors.initials: R
authors.lastname: Madan
authors.forename: Douglas T
authors.initials: DT
authors.lastname: Golenbock
authors.forename: Alberto
authors.initials: A
authors.lastname: Visintin
authors.forename: Robert W
authors.initials: RW
authors.lastname: Finberg
authors.forename: Alexander
authors.initials: A
authors.lastname: Tarakhovsky
authors.forename: Stefanie N
authors.initials: SN
authors.lastname: Vogel
authors.forename: Yasmine
authors.initials: Y
authors.lastname: Belkaid
authors.forename: Evelyn A
authors.initials: EA
authors.lastname: Kurt-Jones
authors.forename: Christopher L
authors.initials: CL
authors.lastname: Karp
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000235:genetics / Q000378:metabolism; D000954:Antigens, Surface / Q000235:genetics / Q000378:metabolism*; D001402:B-Lymphocytes / Q000276:immunology*; D002460:Cell Line; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D051218:Lymphocyte Antigen 96 / Q000037:antagonists & inhibitors* / Q000235:genetics; D017737:Macrophages, Peritoneal / Q000276:immunology; D008562:Membrane Glycoproteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D015398:Signal Transduction; D051197:Toll-Like Receptor 4 / Q000037:antagonists & inhibitors*
chemical_list: D015703:Antigens, CD; D000954:Antigens, Surface; D051218:Lymphocyte Antigen 96; D008562:Membrane Glycoproteins; D051197:Toll-Like Receptor 4